Fulcrum therapeutics inc may have engaged in securities fraud and the schall law firm encourages affected investors to join an inquiry

Los angeles, ca / accesswire / september 22, 2024 / the schall law firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of fulcrum therapeutics, inc. ("fulcrum" or "the company") (nasdaq:fulc) for violations of the securities laws. the investigation focuses on whether the company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
FULC Ratings Summary
FULC Quant Ranking